Miguel A Pavlovsky

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymp...

Ibrutinib plus bendamustine-rituximab versus placebo plus bendamustine-rituximab bij recidief CLL/SLL